Provided is an inorganic composite compound having reduced oxygen and a high reducing ability, which includes elements having a positive atomic valence of a plant-derived component and a sulfur compound. The compound provides a therapeutic treatment effect and a pharmacological effect and is useful to suppress the influence of active oxygen (oxidization) and cannot be produced by a synthetic chemical technique. A method of producing the same is also provided.

Provided is an inorganic composite compound having reduced oxygen and a high reducing ability, which includes elements having a positive atomic valence of a plant-derived component and a sulfur compound. The compound provides a therapeutic treatment effect and a pharmacological effect and is useful to suppress the influence of active oxygen (oxidization) and cannot be produced by a synthetic chemical technique. A method of producing the same is also provided.

The present invention relates to a formulation that can be utilised to facilitate expression of natural behaviour in pigs, and in particular sows and weaners and a method which utilises the formulation for the same.

The present invention relates to a formulation that can be utilised to facilitate expression of natural behaviour in pigs, and in particular sows and weaners and a method which utilises the formulation for the same.

Methods and compositions for increasing intestinal transport of nutrients or growth performance in the offspring of an animal are described. More specifically, a feed composition comprising an omega-3 fatty acid-containing composition for increasing intestinal transport of nutrients or growth performance in the offspring of the animal, and methods therefor, are described.

The present invention relates to compositions comprising thymol for use in the preventive and/or curative treatment of inflammatory or functional diseases of the intestinal tract and related symptoms in human subjects, or monogastric animals, or poultry or fish by modulating the receptors and/or enzymes of the endocannabinoid system.

The present invention relates to compositions comprising thymol for use in the preventive and/or curative treatment of inflammatory or functional diseases of the intestinal tract and related symptoms in human subjects, or monogastric animals, or poultry or fish by modulating the receptors and/or enzymes of the endocannabinoid system.

This invention discloses method for feeding Hermetia illucens and used as for preparing composite material of puparium, which comprises the following steps: S1, dry Hermetia illucens pupariums and grind them into powdery, S2, adding powdery of Hermetia illucens pupariums into sodium hydroxide aqueous solution, stirring, separating and filtering, S3, adding the pupariums into hydrochloric acid solution, stirring, separating and filtering; S4, placing the pupariums into sodium hydroxide aqueous solution, stirring, separating and filtering; S5, drying the pupariums, and screening out the granular pretreated powder of the Hermetia illucens pupariums. The invention also disclose preparation method of composite material and thin film of Hermetia illucens pupariums and antibacterial and antimildew additive. The method can effectively improve the yield of chitosan in Hermetia illucens pupariums, and the prepared pupariums powder can be used for preparing polymer composite fibers and thin films of the Hermetia illucens pupariums, thus, the antibacterial effect is greatly improved. A new antibacterial and antimycotic additive can be obtained by compounding the powder of Hermetia illucens pupariums with the powder of oyster shell.

The invention is directed to a hypertension animal model, and methods of using the same to induce heart failure with preserved ejection fraction (HFpEF) responses.

The invention is directed to a hypertension animal model, and methods of using the same to induce heart failure with preserved ejection fraction (HFpEF) responses.